STOCKS SLIP AS WAIT FOR NVIDIA EARNINGS NEARS END

BuzzFeed shares soar after Vivek Ramaswamy discloses 7.7% stake

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

3.4700

+0.1100

(+3.27%)

As of 12:45PM EDT. Market open.

Loading interactive chart...

Thomson Reuters StreetEvents
Q1 2024 Omeros Corp Earnings Call
Q1 2024 Omeros Corp Earnings Call
GuruFocus.com
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
Business Wire
Omeros Corporation Reports First Quarter 2024 Financial Results
SEATTLE, May 15, 2024--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024, which include: